Viewing Study NCT04754594


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-01-04 @ 4:51 PM
Study NCT ID: NCT04754594
Status: COMPLETED
Last Update Posted: 2024-12-06
First Post: 2021-02-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
Sponsor: BioNTech SE
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C4591015
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View